Cat.#: ACPP-1314
| Despition | Syndecan-1 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1298 | Syndecan-1 Blocking Peptide (AC1298) | 250 µg | inquiry |
| ACPP-1612 | Human Vimentin Protein, GST (AC1612) | 2 µg | inquiry |
| ACPP-1426 | Human ENO2 Protein (AC1426) | 5 µg | inquiry |
| ACPP-1793 | Human HSPB8 Protein, His (AC1793) | 2 µg | inquiry |
| ACPP-1782 | TPX E.coli (AC1782) | 5 µg | inquiry |
| ACPP-1828 | Human EPHA2 Protein (AC1828) | 2 µg | inquiry |
| ACPP-1599 | Human CHGB Protein (AC1599) | 2 µg | inquiry |
| ACPP-1245 | CRMP2 Blocking Peptide (AC1245) | 250 µg | inquiry |
| ACPP-1410 | Human MEOX2 Protein (AC1410) | 2 µg | inquiry |
| ACPP-1412 | Human SLC4A4 Protein (AC1412) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.